Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


16.10.2017

1 BMC Cancer
2 Br J Neurosurg
2 Cancer
1 Cancer Res
1 Clin Cancer Res
2 Int J Cancer
1 J Neurol
5 J Neurooncol
36 Neuro Oncol
4 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. KIM S, Nam SJ, Kwon D, Kim H, et al
    MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
    BMC Cancer. 2016;16:363.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  2. MIRZA FA, Wang C, Pittman T
    Can patients safely be admitted to a ward after craniotomy for resection of intra-axial brain tumors?
    Br J Neurosurg. 2017 Oct 11:1-5. doi: 10.1080/02688697.2017.1390064.
    PubMed     Text format     Abstract available

  3. JIMENEZ-VAZQUEZ O, Nagore N
    Neuroendoscopic and histopathological correlation in 13 cases of cystic fluid filled brain tumours.
    Br J Neurosurg. 2017 Oct 9:1-3. doi: 10.1080/02688697.2017.1384791.
    PubMed     Text format     Abstract available


    Cancer

  4. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Cancer. 2017 Oct 12. doi: 10.1002/cncr.30946.
    PubMed     Text format     Abstract available

  5. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


    Cancer Res

  6. LIU Y, Yuelling LW, Wang Y, Du F, et al
    Astrocytes promote medulloblastoma progression through hedgehog secretion.
    Cancer Res. 2017 Oct 6. pii: canres.1463.2017.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. ACERBI F, Broggi M, Schebesch KM, Hohne J, et al
    Fluorescein-guided surgery for resection of high-grade gliomas: A multicentric prospective phase II study (FLUOGLIO).
    Clin Cancer Res. 2017 Oct 10. pii: clincanres.1184.2017.
    PubMed     Text format     Abstract available


    Int J Cancer

  8. PIEL C, Pouchieu C, Tual S, Migault L, et al
    Central nervous system tumors and agricultural exposures in the prospective cohort AGRICAN.
    Int J Cancer. 2017;141:1771-1782.
    PubMed     Text format     Abstract available

  9. SRIVASTAVA C, Irshad K, Dikshit B, Chattopadhyay P, et al
    FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Int J Cancer. 2017 Oct 9. doi: 10.1002/ijc.31092.
    PubMed     Text format     Abstract available


    J Neurol

  10. DECAVELE M, Weiss N, Rivals I, Prodanovic H, et al
    Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience.
    J Neurol. 2017 Oct 9. doi: 10.1007/s00415-017-8624.
    PubMed     Text format     Abstract available


    J Neurooncol

  11. DUERINCK J, Du Four S, Bouttens F, Andre C, et al
    Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2629.
    PubMed     Text format     Abstract available

  12. DONOHO DA, Wen T, Babadjouni RM, Schwartzman W, et al
    Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2625.
    PubMed     Text format     Abstract available

  13. NGHIEMPHU PL, Ebiana VA, Wen P, Gilbert M, et al
    Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2624.
    PubMed     Text format     Abstract available

  14. DE B, Beal K, De Braganca KC, Souweidane MM, et al
    Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.
    J Neurooncol. 2017 Oct 10. doi: 10.1007/s11060-017-2627.
    PubMed     Text format     Abstract available

  15. LUKAS RV, Lesniak MS, Stupp R
    Hospital volume and group expertise in newly diagnosed glioblastoma management.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2632.
    PubMed     Text format    


    Neuro Oncol

  16. JAHAN N, Talat H, Curry WT
    Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells.
    Neuro Oncol. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. LANG FM, Hossain A, Gumin J, Momin EN, et al
    Mesenchymal Stem Cells as Natural Bio-Factories for Exosomes Carrying miR-124a in the Treatment of Gliomas.
    Neuro Oncol. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. PRIDHAM KJ, Le L, Guo S, Varghese RT, et al
    PIK3CB/p110beta is a Selective Survival Factor for Glioblastoma.
    Neuro Oncol. 2017 Sep 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. JONES DTW, Kieran MW, Bouffet E, Alexandrescu S, et al
    Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.
    Neuro Oncol. 2017 Aug 2. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. SZULZEWSKY F, Schwendinger N, Guneykaya D, Cimino PJ, et al
    Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Neuro Oncol. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. MANDEL JJ, Yust-Katz S, Patel AJ, Cachia D, et al
    Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.
    Neuro Oncol. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. SHAN X, Fan X, Liu X, Zhao Z, et al
    Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis.
    Neuro Oncol. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. DEWITT JC, Jordan JT, Frosch MP, Samore WR, et al
    Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.
    Neuro Oncol. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. AOKI K, Nakamura H, Suzuki H, Matsuo K, et al
    Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
    Neuro Oncol. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. DAGMAR D, Proescholdt M, Reinert C, Pietsch T, et al
    Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
    Neuro Oncol. 2017 Aug 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. KHAGI S, Miller CR
    Putting "multiforme" back into glioblastoma: intratumoral transcriptome heterogeneity is a consequence of its complex morphology.
    Neuro Oncol. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format    

  27. TIROSH I, Suva ML
    Dissecting human gliomas by single-cell RNA sequencing.
    Neuro Oncol. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. RAHME GJ, Luikart BW, Cheng C, Israel MA, et al
    A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
    Neuro Oncol. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. KESSLER T, Sahm F, Sadik A, Stichel D, et al
    Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
    Neuro Oncol. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. TAUNK NK, Oh JH, Shukla-Dave A, Beal K, et al
    Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery.
    Neuro Oncol. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. WICK A, Kessler T, Elia AEH, Winkler F, et al
    Glioblastoma in the elderly: solid conclusions built on shifting sand?
    Neuro Oncol. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. SCHREIBER JE, Palmer SL, Conklin HM, Mabbott DJ, et al
    Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.
    Neuro Oncol. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. LEVESLEY J, Steele L, Bruning-Richardson A, Davison A, et al
    Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells.
    Neuro Oncol. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. WIJNENGA MMJ, French PJ, Dubbink HJ, Dinjens WNM, et al
    The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological and molecular analysis.
    Neuro Oncol. 2017 Sep 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. PHILIP J, Collins A, Brand C, Sundararajan V, et al
    A Proposed Framework of Supportive and Palliative Care for people with High Grade Glioma.
    Neuro Oncol. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. GALANIS E, Anderson SK, Miller CR, Sarkaria JN, et al
    Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Final Results of Alliance N0874/ABTC 02.
    Neuro Oncol. 2017 Aug 22. doi: 10.1093.
    PubMed     Text format     Abstract available

  37. WEN PY, Drappatz J, de Groot J, Prados MD, et al
    Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.
    Neuro Oncol. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available

  38. ANDERSEN ZJ, Pedersen M, Weinmayr G, Stafoggia M, et al
    Long-term Exposure to Ambient Air Pollution and Incidence of Brain Tumor: the European Study of Cohorts for Air Pollution Effects (ESCAPE).
    Neuro Oncol. 2017 Aug 31. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. HARDY KK, Willard VW, Gioia A, Sharkey C, et al
    Attention-mediated neurocognitive profiles in survivors of pediatric brain tumors: Comparison to children with neurodevelopmental ADHD.
    Neuro Oncol. 2017 Sep 8. doi: 10.1093.
    PubMed     Text format     Abstract available

  40. COULDWELL WT, Cannon-Albright LA
    A description of familial clustering of meningiomas in the Utah population.
    Neuro Oncol. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. POETSCH N, Woehrer A, Gesperger J, Furtner J, et al
    Visual and semiquantitative 11C-methionine PET: An independent prognostic factor for survival of newly diagnosed and treatment naive gliomas.
    Neuro Oncol. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  42. NOWOSIELSKI M, Ellingson BM, Chinot OL, Garcia J, et al
    Radiologic progression of glioblastoma under therapy - an exploratory analysis of AVAglio.
    Neuro Oncol. 2017 Sep 1. doi: 10.1093.
    PubMed     Text format     Abstract available

  43. SPERANZA MC, Passaro C, Ricklefs F, Kasai K, et al
    Preclinical investigation of gene-mediated cytotoxic immunotherapy and checkpoint blockade in glioblastoma.
    Neuro Oncol. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  44. BHERE D, Tamura K, Wakimoto H, Choi SH, et al
    microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
    Neuro Oncol. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  45. BIELAMOWICZ K, Fousek K, Byrd TT, Samaha H, et al
    Trivalent CAR T-cells Overcome Interpatient Antigenic Variability in Glioblastoma.
    Neuro Oncol. 2017 Sep 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  46. SHIBAO S, Minami N, Koike N, Fukui N, et al
    Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Neuro Oncol. 2017 Sep 2. doi: 10.1093.
    PubMed     Text format     Abstract available

  47. KARREMANN M, Gielen GH, Hoffmann M, Wiese M, et al
    Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Neuro Oncol. 2017 Aug 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  48. SARKARIA JN, Hu LS, Parney IF, Pafundi DH, et al
    Is the blood-brain barrier really disrupted in all glioblastomas? - A critical assessment of existing clinical data.
    Neuro Oncol. 2017 Sep 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  49. HEFFRON TP
    Challenges of developing small molecule kinase inhibitors for brain tumors and the need for emphasis on free drug levels.
    Neuro Oncol. 2017 Sep 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  50. GARNIER D, Meehan B, Kislinger T, Daniel P, et al
    Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
    Neuro Oncol. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  51. WU S, Wang S, Gao F, Li L, et al
    Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.
    Neuro Oncol. 2017 Jul 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  52. CASTRO BA, Flanigan P, Jahangiri A, Hoffman D, et al
    Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Oncogene. 2017;36:3749-3759.
    PubMed     Text format     Abstract available

  53. YANG JM, Schiapparelli P, Nguyen HN, Igarashi A, et al
    Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Oncogene. 2017;36:3673-3685.
    PubMed     Text format     Abstract available

  54. CHEN D, Fan Z, Rauh M, Buchfelder M, et al
    ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Oncogene. 2017;36:5593-5608.
    PubMed     Text format     Abstract available

  55. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: